A 2019 online survey of 3634 medicinal cannabis users has identified factors predictive of intention to engage with the new prescription Medicinal Cannabis Scheme (MCS) in New Zealand. A total of 78% of respondents were aware of the new MCS and 66% intended to use it. On logistic regression analysis, higher income (odds ratio [OR] 1.57), younger age (OR 1.02), smoking cannabis versus vaping (OR 2.0), and oral ingestion in edible form (OR 2.22) predicted intention to engage with the MCS. Those less likely to engage with the MCS were Māori (OR 0.63) and those who grew their own cannabis (OR 0.52). The authors speculated that lower intended engagement by Māori, lower income groups and those who grow their own cannabis may reflect perceptions of the MCS as restrictive and expensive.